Mettler-Toledo International, Inc. (MTD)
1722.15
+43.07
(+2.57%)
USD |
NYSE |
Nov 06, 16:00
1721.76
-0.39
(-0.02%)
Pre-Market: 20:00
Mettler-Toledo International Research and Development Expense (Quarterly) : 52.99M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.99M |
| March 31, 2026 | 51.28M |
| December 31, 2025 | 52.60M |
| September 30, 2025 | 51.14M |
| June 30, 2025 | 49.28M |
| March 31, 2025 | 46.35M |
| December 31, 2024 | 50.05M |
| September 30, 2024 | 47.12M |
| June 30, 2024 | 45.77M |
| March 31, 2024 | 46.42M |
| December 31, 2023 | 46.44M |
| September 30, 2023 | 46.13M |
| June 30, 2023 | 47.24M |
| March 31, 2023 | 45.48M |
| December 31, 2022 | 45.94M |
| September 30, 2022 | 44.13M |
| June 30, 2022 | 44.02M |
| March 31, 2022 | 43.03M |
| December 31, 2021 | 45.62M |
| September 30, 2021 | 42.28M |
| June 30, 2021 | 42.60M |
| March 31, 2021 | 39.27M |
| December 31, 2020 | 39.87M |
| September 30, 2020 | 34.66M |
| June 30, 2020 | 31.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 34.39M |
| December 31, 2019 | 35.30M |
| September 30, 2019 | 36.02M |
| June 30, 2019 | 36.58M |
| March 31, 2019 | 36.05M |
| December 31, 2018 | 36.20M |
| September 30, 2018 | 34.84M |
| June 30, 2018 | 35.32M |
| March 31, 2018 | 34.71M |
| December 31, 2017 | 32.54M |
| September 30, 2017 | 32.20M |
| June 30, 2017 | 32.58M |
| March 31, 2017 | 31.39M |
| December 31, 2016 | 30.16M |
| September 30, 2016 | 30.14M |
| June 30, 2016 | 30.70M |
| March 31, 2016 | 28.97M |
| December 31, 2015 | 31.11M |
| September 30, 2015 | 29.71M |
| June 30, 2015 | 29.79M |
| March 31, 2015 | 28.46M |
| December 31, 2014 | 31.32M |
| September 30, 2014 | 30.35M |
| June 30, 2014 | 32.12M |
| March 31, 2014 | 29.50M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 120.00M |
| Illumina, Inc. | 249.00M |
| Revvity, Inc. | 48.11M |
| Thermo Fisher Scientific, Inc. | 348.00M |
| Bio-Rad Laboratories, Inc. | 60.30M |